Publicaciones en la fuente ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Tipo Año Título Fuente
Artículo2022Characterization of Extended-Spectrum beta-Lactamase-Producing Shigella sonnei in Spain: Expanding the Geographic Distribution of Sequence Type 152/CTX-M-27 CloneANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2022Development of an Anti-Acinetobacter baumannii Biofilm Phage Cocktail: Genomic Adaptation to the HostANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2022Early use of Sarilumab in patients hospitalised with COVID-19 pneumonia and features of systemic inflammation.ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2022In vitro activity of cefepime-taniborbactam against carbapenemase-producing enterobacterales and pseudomonas aeruginosa isolates recovered in SpainANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Activity of fosfomycin and amikacin against fosfomycin-heteroresistant Escherichia coli strains in a hollow-fiber infection modelANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Amikacin combined with fosfomycin for treatment of neonatal sepsis in the setting of highly prevalent antimicrobial resistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: results from a Spanish multicenter cohortANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Enhanced antibacterial activity of repurposed mitomycin C and imipenem in combination with the lytic phage vB_KpnMVAC13 against clinical isolates of klebsiella pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Corrección2021Erratum for Herrera-Hidalgo et al., "Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs?"ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Corrección2021Erratum: Ampicillin and ceftriaxone solution stability at different temperatures in outpatient parenteral antimicrobial therapy (Antimicrobial Agents and Chemotherapy (2020) 64:7 (e00309-20) DOI: 10.1128/AAC.00309-20)ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Interplay among different fosfomycin resistance mechanisms in klebsiella pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Is once-daily high-dose ceftriaxone plus ampicillin an alternative for enterococcus faecalis infective endocarditis in outpatient parenteral antibiotic therapy programs?ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipientsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2021Synergistic quinolone sensitization by targeting the recA SOS response gene and oxidative stressANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020A randomized, double-blind, placebo-controlled trial (TAURCAT Study) of citrate lock solution for prevention of endoluminal central venous catheter infection in neutropenic hematological patientsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020Activity of Imipenem-Relebactam against a Large Collection of Pseudomonas aeruginosa Clinical Isolates and lsogenic beta-Lactam-Resistant MutantsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020Ampicillin and Ceftriaxone Solution Stability at Different Temperatures in Outpatient Parenteral Antimicrobial TherapyANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020Clinical Predictive Model of Multidrug Resistance in Neutropenic Cancer Patients with Bloodstream Infection Due to Pseudomonas aeruginosaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020Impact of KPC production and high-level meropenem resistance on all-cause mortality of ventilator-associated pneumonia in association with klebsiella pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020Modulation of monocyte activation and function during direct antiviral agents treatment in HIV coinfected patientsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2020Unexpected Cell Wall Alteration-Mediated Bactericidal Activity of the Antifungal Caspofungin against Vancomycin-Resistant Enterococcus faeciumANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2019Investigation of Novel pmrB and eptA Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence In VivoANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2019OXA-48-Like-Producing Klebsiella pneumoniae in Southern Spain in 2014-2015ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2019Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint InfectionsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter2018Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2018Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study)ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2018Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff ValuesANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2018Relationship between Tolerance and Persistence Mechanisms in Acinetobacter baumannii Strains with AbkAB Toxin-Antitoxin SystemANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2018Urinary Tract Conditions Affect Fosfomycin Activity against Escherichia coli Strains Harboring Chromosomal Mutations Involved in Fosfomycin UptakeANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2017Efficacy of beta-Lactam/beta-Lactamase Inhibitor Combinations for the Treatment of Bloodstream Infection Due to Extended-Spectrum-beta-Lactamase-Producing Enterobacteriaceae in Hematological Patients with NeutropeniaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Corrección2017Erratum for Martínez-Florensa et al., "Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial Sepsis"ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2017Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and CarbapenemsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2017Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion MethodANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2017Plasmidic qnr Genes Confer Clinical Resistance to Ciprofloxacin under Urinary Tract Physiological ConditionsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2017Protective Effects of Human and Mouse Soluble Scavenger-Like CD6 Lymphocyte Receptor in a Lethal Model of Polymicrobial SepsisANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016A Multinational, Preregistered Cohort Study of beta-Lactam/beta-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-beta-Lactamase-Producing EnterobacteriaceaeANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016Activity of Ceftazidime-Avibactam against Clinical and Isogenic Laboratory Pseudomonas aeruginosa Isolates Expressing Combinations of Most Relevant beta-Lactam Resistance MechanismsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016Deciphering the Resistome of the Widespread Pseudomonas aeruginosa Sequence Type 175 International High-Risk Clone through Whole-Genome SequencingANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016Efficacy of Lysophosphatidylcholine in Combination with Antimicrobial Agents against Acinetobacter baumannii in Experimental Murine Peritoneal Sepsis and Pneumonia ModelsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Revisión2016Optimizing the Clinical Use of VancomycinANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016Pharmacodynamics of Voriconazole in Children: Further Steps along the Path to True Individualized TherapyANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coliANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2016Validation of the HIV Tropism Test TROCAI Using the Virological Response to a Short-Term Maraviroc Monotherapy ExposureANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2015Effects of a mutation in the gyrA gene on the virulence of uropathogenic Escherichia coliANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2015Mobile Genetic Elements Related to the Diffusion of Plasmid-Mediated AmpC beta-Lactamases or Carbapenemases from Enterobacteriaceae: Findings from a Multicenter Study in SpainANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2015Pharmacodynamics of Fosfomycin: Insights into Clinical Use for Antimicrobial ResistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2015Prospective Multicenter Study of Carbapenemase-Producing Enterobacteriaceae from 83 Hospitals in Spain Reveals High In Vitro Susceptibility to Colistin and MeropenemANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2015Telaprevir and Ribavirin Interaction: Higher Ribavirin Levels Are Not Only Due to Renal Dysfunction during Triple TherapyANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Editorial2015The Times They Are a-Changin': Carbapenems for Extended-Spectrum-beta-Lactamase-Producing BacteriaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014Activity of Host Antimicrobials against Multidrug-Resistant Acinetobacter baumannii Acquiring Colistin Resistance through Loss of LipopolysaccharideANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014Inhibitor-Resistant TEM- and OXA-1-Producing Escherichia coli Isolates Resistant to Amoxicillin-Clavulanate Are More Clonal and Possess Lower Virulence Gene Content than Susceptible Clinical IsolatesANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution MethodANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014Multilaboratory Study of Epidemiological Cutoff Values for Detection of Resistance in Eight Candida Species to Fluconazole, Posaconazole, and VoriconazoleANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014Population Pharmacokinetics of Teicoplanin in ChildrenANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2014Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Colistin Resistance in a Clinical Acinetobacter baumannii Strain Appearing after Colistin Treatment: Effect on Virulence and Bacterial FitnessANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Contribution of Efflux Pumps, Porins, and beta-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Cost-Effectiveness Analysis Comparing Two Approaches for Empirical Antifungal Therapy in Hematological Patients with Persistent Febrile NeutropeniaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013First Report of an OXA-23 Carbapenemase-Producing Acinetobacter baumannii Clinical Isolate Related to Tn2006 in SpainANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Fosfomycin-Daptomycin and Other Fosfomycin Combinations as Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureusANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Impact of the MIC of Piperacillin-Tazobactam on the Outcome of Patients with Bacteremia Due to Extended-Spectrum-beta-Lactamase-Producing Escherichia coliANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Inoculum Effect on the Efficacies of Amoxicillin-Clavulanate, Piperacillin-Tazobactam, and Imipenem against Extended-Spectrum beta-Lactamase (ESBL)-Producing and Non-ESBL-Producing Escherichia coli in an Experimental Murine Sepsis ModelANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Lopinavir Plasma Concentrations and Virological Outcome with Lopinavir-Ritonavir Monotherapy in HIV-1-Infected PatientsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter2013Loss of the OprD Homologue Protein in Acinetobacter baumannii: Impact on Carbapenem SusceptibilityANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2013Multicenter Study of Isavuconazole MIC Distributions and Epidemiological Cutoff Values for Aspergillus spp. for the CLSI M38-A2 Broth Microdilution MethodANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Correlation of the Virological Response to Short-Term Maraviroc Monotherapy with Standard and Deep-Sequencing-Based Genotypic Tropism Prediction MethodsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Effect of Maraviroc on HIV Disease Progression-Related BiomarkersANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Efficacy of Daptomycin versus Vancomycin in an Experimental Model of Foreign-Body and Systemic Infection Caused by Biofilm Producers and Methicillin-Resistant Staphylococcus epidermidisANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Efficacy of Daptomycin-Cloxacillin Combination in Experimental Foreign-Body Infection Due to Methicillin-Resistant Staphylococcus aureusANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Genomewide Overexpression Screen for Fosfomycin Resistance in Escherichia coli: MurA Confers Clinical Resistance at Low Fitness CostANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012HIV-1 Tropism Evolution after Short-Term Maraviroc Monotherapy in HIV-1-Infected PatientsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Impact of Inadequate Empirical Therapy on the Mortality of Patients with Bloodstream Infections: a Propensity Score-Based AnalysisANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Prospective Multicenter Study of the Impact of Carbapenem Resistance on Mortality in Pseudomonas aeruginosa Bloodstream InfectionsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2012Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coliANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2011Analysis of Genes Encoding Penicillin-Binding Proteins in Clinical Isolates of Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2011First Face Composite-Tissue Transplant Recipient Successfully Treated for Cytomegalovirus Infection with Preemptive Valganciclovir TreatmentANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2011In Vitro Effect of qnrA1, qnrB1, and qnrS1 Genes on Fluoroquinolone Activity against Isogenic Escherichia coli Isolates with Mutations in gyrA and parCANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2011Virological Response after Short-Term CCR5 Antagonist Exposure in HIV-Infected Patients: Frequency of Subjects with Virological Response and Associated FactorsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010Antimicrobial Resistance among Respiratory Pathogens in Spain: Latest Data and Changes over 11 Years (1996-1997 to 2006-2007)ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010Characterization of DIM-1, an Integron-Encoded Metallo-beta-Lactamase from a Pseudomonas stutzeri Clinical Isolate in the NetherlandsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010Efficacy of Rifampin and Its Combinations with Imipenem, Sulbactam, and Colistin in Experimental Models of Infection Caused by Imipenem-Resistant Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010Efficacy of Usual and High Doses of Daptomycin in Combination with Rifampin versus Alternative Therapies in Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureusANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010Extended-Spectrum Cephalosporinase in Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010Genetic and functional variability of AmpC-type â-lactamases from Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010Risk Factors for Fluconazole-Resistant CandidemiaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2010VIM-19, a Metallo-beta-Lactamase with Increased Carbapenemase Activity from Escherichia coli and Klebsiella pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2009Efficacy of High Doses of Daptomycin versus Alternative Therapies against Experimental Foreign-Body Infection by Methicillin-Resistant Staphylococcus aureusANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2009Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2009Genetic Variability among ampC Genes from Acinetobacter Genomic Species 3ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter2009In Vitro Activities of Tigecycline, Minocycline, and Colistin-Tigecycline Combination against Multi- and Pandrug-Resistant Clinical Isolates of Acinetobacter baumannii GroupANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2009In Vitro Activity and In Vivo Efficacy of Clavulanic Acid against Acinetobacter baumanniiANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2009Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2009Naturally Occurring Class A beta-Lactamases from the Burkholderia cepacia ComplexANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2009Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic ImpairmentANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2008Characterization of the carbapenem-hydrolyzing oxacillinase Oxa-58 in an Acinetobacter genospecies 3 clinical isolateANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter2008Plasmid-mediated QnrS2 determinant from a clinical Aeromonas veronii isolateANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Editorial2008qnr gene nomenclatureANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2007Clinical and pharmacokinetic data support once-daily low-dose boosted saquinavir (1,200 milligrams saquinavir with 100 milligrams ritonavir) in treatment-naive or limited protease inhibitor-experienced human immunodeficiency virus-infected patientsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2007Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2006Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: Molecular basis for the differential mechanisms of actionANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2006Common region CR1 for expression of antibiotic resistance genesANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2006Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi: Comparison with CLSI broth microdilution methodANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2006In vitro activity of fosfomycin against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: Comparison of susceptibility testing proceduresANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2006In vivo selection of fluoroquinolone-resistant Escherichia coli isolates expressing plasmid-mediated quinolone resistance and expanded-spectrum beta-lactamaseANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2006Intracellular penetration and activity of DX-619 in human polymorphonuclear leukocytesANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2005Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-lactamaseANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2005Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in SpainANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2005Origin of plasmid-mediated quinolone resistance determinant QNRAANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2005Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: Correlation with results of NCCLS M27-A2 multicenter studyANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2004Activity of tigecycline (GAR-936) against Acinetobacter baumannii strains, including those resistant to imipenemANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2004Antimicrobial susceptibility and mechanisms of resistance to quinolones and beta-lactams in Acinetobacter genospecies 3ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter2004Type 1 integrons in epidemiologically unrelated Acinetobacter baumannii isolates collected at Spanish hospitalsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2003Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interestANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2003Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistanceANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2003Zinc eluted from siliconized latex urinary catheters decreases OprD expression, causing carbapenem resistance in Pseudomonas aeruginosaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2002Energy-dependent accumulation of norfloxacin and porin expression in clinical isolates of Klebsiella pneumoniae and relationship to extended-spectrum beta-lactamase productionANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2002Uptake and intracellular activity of linezolid in human phagocytes and nonphagocytic cellsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2001Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2000Activities of imipenem and cephalosporins against clonally related strains of Escherichia coli hyperproducing chromosomal beta-lactamase and showing altered porin profilesANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2000Correlation of fluconazole MICs with clinical outcome in Cryptococcal infectionANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2000Intracellular penetration and activity of gemifloxacin in human polymorphonuclear leukocytesANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo2000Intravitreal, retinal, and central nervous system foscarnet concentrations after rapid intravenous administration to rabbitsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1999Development of resistance during antimicrobial therapy caused by insertion sequence interruption of porin genesANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1999Resistance of Pseudomonas aeruginosa to imipenem induced by eluates from siliconized latex urinary catheters is related to outer membrane protein alterationsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1999Roles of beta-lactamases and porins is activities of carbapenems and cephalosporins against Klebsiella pneumoniaeANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1999Uptake and intracellular activity of moxifloxacin in human neutrophils and tissue-cultured epithelial cellsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1998Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strainsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Corrección1998Energy-dependent accumulation of fluoroquinolones in quinolone-resistant Klebsiella pneumoniae strains (vol 42, pg 1850, 1998)ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1998In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteriaANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter1997Ergotism related to concurrent administration of ergotamine tartrate and ritonavir in an AIDS patientANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1997Uptake and intracellular activity of trovafloxacin in human phagocytes and tissue-cultured epithelial cellsANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1996Absence of effect of trimethoprim-sulfamethoxazole on pharmacokinetics of zidovudine in patients infected with human immunodeficiency virusANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1996Antimicrobial susceptibility pattern of Corynebacterium striatumANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Letter1996Cefuroxime efficacy in treatment of bacteremic pneumonia due to penicillin-resistant and cefuroxime-resistant Streptococcus pneumoniae ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1995Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal-fluid of and cerebral extracellular-space in awake rats by in-vivo microdialysisANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1995DOXYCYCLINE-RIFAMPIN VERSUS DOXYCYCLINE-STREPTOMYCIN IN TREATMENT OF HUMAN BRUCELLOSIS DUE TO BRUCELLA-MELITENSISANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Nota1994COMPARATIVE ACTIVITIES OF 8 QUINOLONES AGAINST MEMBERS OF THE BACTEROIDES-FRAGILIS GROUPANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1994INTRACELLULAR PENETRATION AND ACTIVITY OF BAY-Y-3118 IN HUMAN POLYMORPHONUCLEAR LEUKOCYTESANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1993UPTAKE AND INTRACELLULAR ACTIVITY OF FLUCONAZOLE IN HUMAN POLYMORPHONUCLEAR LEUKOCYTESANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1992UPTAKE AND INTRACELLULAR ACTIVITY OF SPARFLOXACIN IN HUMAN POLYMORPHONUCLEAR LEUKOCYTES AND TISSUE-CULTURE CELLSANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1990MULTICENTER PROSPECTIVE-STUDY OF TREATMENT OF BRUCELLA-MELITENSIS BRUCELLOSIS WITH DOXYCYCLINE FOR 6 WEEKS PLUS STREPTOMYCIN FOR 2 WEEKSANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1990UPTAKE AND INTRACELLULAR ACTIVITY OF AN OPTICALLY-ACTIVE OFLOXACIN ISOMER IN HUMAN NEUTROPHILS AND TISSUE-CULTURE CELLSANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1989FLUOROMETRIC MEASUREMENT OF OFLOXACIN UPTAKE BY HUMAN POLYMORPHONUCLEAR LEUKOCYTESANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Nota1986EFFECT OF MEDIUM, PH, AND INOCULUM SIZE ON ACTIVITY OF CEFTIZOXIME AND SCH-34343 AGAINST ANAEROBIC-BACTERIAANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1985ACTIVITIES OF NEW QUINOLINE DERIVATIVES AGAINST GENITAL PATHOGENSANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Artículo1980COMPARATIVE INVITRO ACTIVITY OF 1-OXA-BETA-LACTAM (LY127935) AND CEFOPERAZONE WITH OTHER BETA-LACTAM ANTIBIOTICS AGAINST ANAEROBIC-BACTERIAANTIMICROBIAL AGENTS AND CHEMOTHERAPY